We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
(+41%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
38.29%
Top 10 Holdings %
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$13.6M |
| 2 |
Merck
MRK
|
+$12.5M |
| 3 |
Intuitive Surgical
ISRG
|
+$11.1M |
| 4 |
DOCU
DocuSign
DOCU
|
+$10.9M |
| 5 |
Insulet
PODD
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$7.26M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$6.86M |
| 3 |
Incyte
INCY
|
+$6.31M |
| 4 |
Fidelity National Information Services
FIS
|
+$5.73M |
| 5 |
AbbVie
ABBV
|
+$4.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Healthcare | 16.13% |
| 4 | Industrials | 12.13% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Campbell Soup
CPB
$6.7B
| $1.82M | 0.21% |
44,389
+32,838
| +284% | +$1.44M |
|
127
Fox Class A
FOXA
$24.9B
| $1.82M | 0.21% |
58,207
-10,766
| -16% | -$354K |
|
128
Restaurant Brands International
QSR
$25.4B
| $1.81M | 0.21% |
+27,182
| New | +$1.95M |
|
129
Electronic Arts
EA
$53B
| $1.81M | 0.21% |
15,036
+5,124
| +52% | +$645K |
|
130
Gartner
IT
$10.1B
| $1.79M | 0.21% |
5,213
-1,685
| -24% | -$588K |
|
131
Futu Holdings
FUTU
$14.9B
| $1.77M | 0.21% |
+30,577
| New | +$1.63M |
|
132
CrowdStrike
CRWD
$199B
| $1.76M | 0.21% |
+42,168
| New | +$1.64M |
|
|
ESTE
133
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.76M | 0.21% |
+87,051
| New | +$1.52M |
|
134
Immunovant
IMVT
$7.89B
| $1.74M | 0.2% |
45,406
-468
| -1% | -$10.6K |
|
135
Jefferies Financial Group
JEF
$12.8B
| $1.74M | 0.2% |
47,581
+36,907
| +346% | +$1.32M |
|
136
Fortinet
FTNT
$120B
| $1.73M | 0.2% |
+29,554
| New | +$1.96M |
|
137
Wells Fargo
WFC
$263B
| $1.73M | 0.2% |
+42,368
| New | +$1.83M |
|
138
D.R. Horton
DHI
$40.6B
| $1.72M | 0.2% |
16,026
+11,002
| +219% | +$1.32M |
|
139
Burlington
BURL
$23.2B
| $1.69M | 0.2% |
12,466
+4,541
| +57% | +$728K |
|
140
Equifax
EFX
$20.6B
| $1.68M | 0.2% |
+9,190
| New | +$1.88M |
|
141
Trade Desk
TTD
$8.72B
| $1.68M | 0.2% |
21,537
-17,356
| -45% | -$1.4M |
|
142
OneMain Financial
OMF
$7.44B
| $1.67M | 0.2% |
+41,714
| New | +$1.78M |
|
143
Union Pacific
UNP
$173B
| $1.67M | 0.2% |
8,206
+853
| +12% | +$186K |
|
144
Roku
ROKU
$21.7B
| $1.67M | 0.19% |
23,591
-20,003
| -46% | -$1.55M |
|
145
Genuine Parts
GPC
$17.6B
| $1.66M | 0.19% |
11,523
+8,255
| +253% | +$1.28M |
|
|
WCN
146
Waste Connections
WCN
$42.3B
| $1.66M | 0.19% |
12,351
+10,453
| +551% | +$1.46M |
|
147
Mattel
MAT
$4.39B
| $1.65M | 0.19% |
75,114
+63,536
| +549% | +$1.36M |
|
148
MSCI
MSCI
$41.5B
| $1.63M | 0.19% |
3,179
-8,552
| -73% | -$4.49M |
|
149
McCormick & Company Non-Voting
MKC
$13.9B
| $1.63M | 0.19% |
+21,546
| New | +$1.8M |
|
150
MaxLinear
MXL
$6.13B
| $1.57M | 0.18% |
+70,404
| New | +$1.79M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.
- Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
- Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
- Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
- Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
- Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
- Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
- Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.
Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.